Patents by Inventor William A. Mallow

William A. Mallow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080254080
    Abstract: A heating ventilation and air conditioning (“HVAC”) system having bacterial spore, viral, and fungal killing activity. The HVAC system components are at least partially coated with a biocidal composition having hydrated lime, soluble binder polymer mixture and humecatant are mixed in either an organic based- or water based-solvent system that is useful for coating HVAC system components.
    Type: Application
    Filed: November 4, 2005
    Publication date: October 16, 2008
    Inventors: Bryan C.G. Glynson, Alis A. Yeterian, John L. Sigalos, William A. Mallow, Nancy Mallow
  • Patent number: 7419942
    Abstract: The present invention relates to a lubricious anti-traction material for effectively denying the mobility and access of personnel and vehicles to selected areas. The anti-traction material is composed of a slurry combined with water. The slurry is composed of an emulsion or dispersion and an anionic acrylamide polymer.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: September 2, 2008
    Assignee: Southwest Research Institute
    Inventors: Nancy J. Mallow, legal representative, Ronald J. Mathis, Andrew Warren, Christian J Schwartz, Errol M. Brigance, Kenneth R. Collins, Nicholle K. Reinhardt, Mary C. Marshall, William A. Mallow
  • Publication number: 20060263406
    Abstract: An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner.
    Type: Application
    Filed: May 1, 2006
    Publication date: November 23, 2006
    Inventors: Mark Lyles, Charles McLaughlin, Glenn Halff, William Mallow
  • Patent number: 7067464
    Abstract: The present invention relates to a lubricious anti-traction material for effectively denying the mobility and access of personnel and vehicles to selected areas. The anti-traction material is composed of a slurry combined with water. The slurry is composed of an emulsion or dispersion and an anionic acrylamide polymer.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: June 27, 2006
    Assignee: Southwest Research Institute
    Inventors: Nancy J. Mallow, Ronald J. Mathis, Andrew Warren, Christian J Schwartz, Errol M. Brigance, Kenneth R. Collins, Nicholle K. Reinhardt, Mary C. Marshall, William A. Mallow
  • Patent number: 7037304
    Abstract: An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: May 2, 2006
    Assignee: Materials Evolution and Development USA, Inc.
    Inventors: Mark B. Lyles, Charles A. McLaughlin, Glenn A. Halff, William A. Mallow
  • Patent number: 7011698
    Abstract: A biocidal film-forming composition, preferably a paint, is disclosed, comprising hydrated lime, alkaline potassium salt, and a non-ionic polyolefinic latex resistant to hydrated-lime induced coagulation and phase separation. Also disclosed is the method of making certain such composition wherein hydrated lime is admixed with a non-ionic polyolefinic ester latex with agitation and continuing such agitation until hydrolysis of the ester is substantially completed and rheology of the composition is stabilized and the incidence of gelation is eliminated.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: March 14, 2006
    Assignee: Alistagen Corporation
    Inventor: William A. Mallow
  • Patent number: 7001371
    Abstract: An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: February 21, 2006
    Assignee: MED USA
    Inventors: Charles A. McLaughlin, Mark B. Lyles, Glenn A. Halff, William A. Mallow
  • Publication number: 20040194656
    Abstract: A biocidal film-forming composition, preferably a paint, is disclosed, comprising hydrated lime, alkaline potassium salt, and a non-ionic polyolefinic latex resistant to hydrated-lime induced coagulation and phase separation. Also disclosed is the method of making certain such composition wherein hydrated lime is admixed with a non-ionic polyolefinic ester latex with agitation and continuing such agitation until hydrolysis of the ester is substantially completed and rheology of the composition is stabilized and the incidence of gelation is eliminated.
    Type: Application
    Filed: June 1, 2004
    Publication date: October 7, 2004
    Inventor: William A Mallow
  • Publication number: 20040059043
    Abstract: The present invention relates to a lubricious anti-traction material for effectively denying the mobility and access of personnel and vehicles to selected areas. The anti-traction material is composed of a slurry combined with water. The slurry is composed of an emulsion or dispersion and an anionic acrylamide polymer.
    Type: Application
    Filed: October 15, 2003
    Publication date: March 25, 2004
    Applicant: SOUTHWEST RESEARCH INSTITUTE
    Inventors: William A. Mallow, Nancy J. Mallow, Ronald J. Mathis, Andrew B. Warren, Christian J. Schwartz, Errol M. Brigance, Kenneth R. Collins, Nicholle K. Reinhardt, Mary C. Marshall
  • Patent number: 6677159
    Abstract: An apparatus and method for visually and continuously monitoring gaseous concentrations of electrophiles such as carbon dioxide. A coating composition comprising an organic binder, filler/pigment, an activator, and carbon dioxide sensitive color indicator interacts with a primed substrate to which it is applied for support. The coated primed substrate may then be used for estimation of carbon dioxide concentration by the detection of a substantially instantaneous and reversible color change of the coated primed substrate.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: January 13, 2004
    Assignee: Southwest Research Institute
    Inventor: William A. Mallow
  • Publication number: 20030144407
    Abstract: The present invention relates to a lubricious anti-traction material for effectively denying the mobility and access of personnel and vehicles to selected areas. The anti-traction material is composed of a slurry combined with water. The slurry is composed of an emulsion or dispersion and an anionic acrylamide polymer.
    Type: Application
    Filed: December 10, 2002
    Publication date: July 31, 2003
    Applicant: Southwest Research Institute
    Inventors: William A. Mallow, Nancy J. Mallow, Ronald J. Mathis, Andrew Warren, Christian J. Schwartz, Errol M. Brigance, Kenneth R. Collins, Nicholle K. Reinhardt, Mary C. Marshall
  • Patent number: 6524543
    Abstract: Disclosed is a commercial grade of soluble silicate solutions, clear homogenous and water white essentially free of unreacted silica, made by dissolving in a closed container biogenic silica, preferably rice hull ash, in a strong alkali solution, preferably sodium hydroxide in the presence of an agent, such as an active carbonaceous material, which prevents discoloration of the soluble silicates by absorbing and/or reacting with polyvalent metals, organic materials, and the like, in the biogenic silica as it dissolves in and reacts with the alkali solution. The invention takes advantage of the residue of such active carbonaceous material on the biogenic silica, such as rice hulls, left by commercial energy burning thereof which effectively prevents discoloration. A solid residue results from the method which is an active carbonaceous material including concentrated manganese from the biogenic silica, both of which are valuable commercial products.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: February 25, 2003
    Inventors: Roy S. Rieber, William A. Mallow, Jesse R. Conner
  • Publication number: 20020120251
    Abstract: An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner.
    Type: Application
    Filed: September 24, 2001
    Publication date: August 29, 2002
    Applicant: MATERIALS EVOLUTION AND DEVELOPMENT USA, INC.
    Inventors: Mark B. Lyles, Charles A. McLaughlin, Glenn A. Halff, William A. Mallow
  • Patent number: 6376022
    Abstract: A thermal barrier protective coating composition having a thickness sufficient to protect a metal surface against heat, vibration, corrosive, and environmental damage and a method for making the same. The coating composition comprises polymerizable spray-dried hydrated sodium silicate powder, a forming agent, and lightweight ceramic microspheres is disclosed.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: April 23, 2002
    Assignee: Southwest Research Institute
    Inventors: William A. Mallow, Clifford A. Moses, Henry L. Bernstein
  • Patent number: 6340360
    Abstract: An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: January 22, 2002
    Assignee: MED USA
    Inventors: Mark B. Lyles, Charles A. McLaughlin, Glenn A. Halff, William A. Mallow
  • Patent number: 6283228
    Abstract: A method for protecting integrity of a core sample during transport from a subterranean formation to the surface comprising: cutting a core sample from the subterranean formation using a drilling fluid; encapsulating the core sample with an encapsulating material that is separate from the drilling fluid and comprises a property which renders the encapsulating material capable of protecting the chemical integrity of the core sample during transport from the subterranean formation to the surface, wherein the property is other than a property selected from the group consisting of a viscosity which increases in response to a decrease in temperature and an ability to solidify in response to a decrease in temperature; and, transporting the encapsulated core sample from the subterranean formation to the surface.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: September 4, 2001
    Assignee: Baker Hughes Incorporated
    Inventors: Pierre Emmanuel Collee, Steven R. Radford, William A. Mallow, Dorothy P. Enright
  • Patent number: 6280509
    Abstract: A biocidal film-forming composition, preferably a paint, is disclosed, comprising hydrated lime and a non-ionic polyolefinic latex resistant to hydrated-lime induced coagulation and phase separation. Also disclosed is the method of making certain such composition wherein hydrated lime is admixed with a non-ionic polyolefinic ester latex with agitation and continuing such agitation until hydrolysis of the ester is substantially completed and rheology of the composition is stabilized.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: August 28, 2001
    Assignee: Alistagen Corporation
    Inventor: William A. Mallow
  • Patent number: 6241711
    Abstract: A face masque that applies cooling therapy to facial features of a patient. The masque is formed of two nylon or plastic layers that define a closed interior space and filled with a cooling medium that includes water, glycerin and hydroxyethyl cellulose. The masque controls the rate of heat dissipation from a user based upon the heat capacity, mass, rheology and composition of the materials used. The masque is lighter than conventional water-filled ice packs. It remains unfrozen and malleable even when cooled to sub-zero temperatures at which water-filled packs would freeze solid. The masque readily conforms to facial features due to the materials used, thereby contributing to improved comfort on the part of a user. Further, the masque possesses improved cooling therapy because it remains cold for longer periods of time relative to water-filled ice packs. Optionally, the masque accommodates eye inserts placed between a main body of the masque and recesses of the patient's eyes.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: June 5, 2001
    Assignee: SkinVestment, LLC
    Inventors: Gloria Weissberg, Tina Alster, Felix Franks, William Mallow
  • Patent number: 6231650
    Abstract: The present invention prolongs the biocidal activity of hydrated lime in a paint or coating by using a sufficient amount of a binder in the paint or coating to block carbon dioxide from reacting with the hydrated lime while still producing a coating that is durable and adhesive upon drying and not unduly friable due to the amount of hydrated lime in said coating.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: May 15, 2001
    Assignee: Alistagen Corporation
    Inventors: William A. Mallow, Bryan Glynson, Larry Rogers
  • Publication number: 20010000393
    Abstract: The present invention provides a method for protecting integrity of a core sample during transport from a subterranean formation to the surface comprising: cutting a core sample from the subterranean formation using a drilling fluid; encapsulating the core sample with an encapsulating material that is separate from said drilling fluid and comprises a property which renders said encapsulating material capable of protecting said chemical integrity of said core sample during transport from said subterranean formation to said surface, wherein said property is other than a property selected from the group consisting of a viscosity which increases in response to a decrease in temperature and an ability to solidify in response to a decrease in temperature; and, transporting said encapsulated core sample from said subterranean formation to said surface.
    Type: Application
    Filed: December 15, 2000
    Publication date: April 26, 2001
    Inventors: Pierre Emmanuel Collee, Steven R. Radford, William A. Mallow, Dorothy P. Enright